254 results on '"Becher, François"'
Search Results
2. A Monoclonal Antibody with a High Affinity for Ricin Isoforms D and E Provides Strong Protection against Ricin Poisoning.
3. Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry
4. Investigating the utility of minimized sample preparation and high-resolution mass spectrometry for quantification of monoclonal antibody drugs
5. A large travel-associated outbreak of iatrogenic botulism in four European countries following intragastric botulinum neurotoxin injections for weight reduction, Türkiye, February to March 2023
6. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
7. High‐throughput untargeted screening of biotherapeutic macromolecules in equine plasma by UHPLC‐HRMS/MS: Application to monoclonal antibodies and Fc‐fusion proteins for doping control.
8. Unambiguous Identification of Ricin and Abrin with Advanced Mass Spectrometric Assays
9. High plasma level of S100A8/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients
10. Functional Assays for Ricin Detection
11. The Yersinia pseudotuberculosis complex: Characterization and delineation of a new species, Yersinia wautersii
12. Detection of Yersinia pestis in Complex Matrices by Intact Cell Immunocapture and Targeted Mass Spectrometry
13. Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
14. Multiplex Detection of 24 Staphylococcal Enterotoxins in Culture Supernatant Using Liquid Chromatography Coupled to High-Resolution Mass Spectrometry
15. Top-Down Mass Spectrometry for Trace Level Quantification of Staphylococcal Enterotoxin A Variants
16. Differentiation, Quantification and Identification of Abrin and Abrus precatorius Agglutinin
17. Additional file 1 of Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
18. Mass Spectrometry Protocol for the Absolute Quantification of a Monoclonal Antibody in Serum with Immunopurification
19. Quantitative Determination of Staphylococcus aureus Enterotoxins Types A to I and Variants in Dairy Food Products by Multiplex Immuno-LC-MS/MS
20. Ricin Antibodies’ Neutralizing Capacity against Different Ricin Isoforms and Cultivars
21. Quantitative Assessment of SARS-CoV-2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins
22. Development and Evaluation of an Immuno-MALDI-TOF Mass Spectrometry Approach for Quantification of the Abrin Toxin in Complex Food Matrices
23. MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides
24. Functional Assays for Ricin Detection
25. Conference Report: 60th American Society for MS Conference on MS and Allied Topics
26. From “Clinical Proteomics” to “Clinical Chemistry Proteomics”: considerations using quantitative mass-spectrometry as a model approach
27. MS-based approaches for studying the pharmacokinetics of protein drugs
28. Optimal Anchoring of a Urea-based Foldamer Inhibitor of ASF1 Histone Chaperone Through Backbone Plasticity
29. Top-Down and Bottom-Up Proteomics of Circulating S100A8/S100A9 in Plasma of Septic Shock Patients
30. Research Spotlight: Drug bioanalysis and biomarker discovery at the Commissariat à l’énergie atomique et aux énergies alternatives
31. Top-Down Mass Spectrometry for Trace Level Quantification of Staphylococcal Enterotoxin A Variants.
32. Supplemental material for Quantification of low abundance Yersinia pestis markers in dried blood spots by immuno-capture and quantitative high-resolution targeted mass spectrometry
33. Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients
34. Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients
35. Liquid chromatography–tandem mass spectrometry assays for intracellular deoxyribonucleotide triphosphate competitors of nucleoside antiretrovirals
36. Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection
37. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay
38. Quantification of low abundance Yersinia pestis markers in dried blood spots by immuno-capture and quantitative high-resolution targeted mass spectrometry
39. Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients
40. Simultaneous quantification of tau and α-synuclein in cerebrospinal fluid by high-resolution mass spectrometry for differentiation of Lewy Body Dementia from Alzheimer's Disease and controls
41. On-a-chip tryptic digestion of transthyretin:A step toward an integrated microfluidic system for the follow-up of familial transthyretin amyloidosis
42. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay.
43. Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection.
44. On-a-chip tryptic digestion of transthyretin: a step toward an integrated microfluidic system for the follow-up of familial transthyretin amyloidosis
45. Quantitative Determination of Staphylococcus aureusEnterotoxins Types A to I and Variants in Dairy Food Products by Multiplex Immuno-LC-MS/MS
46. Tau hyperphosphorylation on T217 in cerebrospinal fluid is specifically associated to amyloid-β pathology
47. Rapid Detection of Abrin Toxin and Its Isoforms in Complex Matrices by Immuno-Extraction and Quantitative High Resolution Targeted Mass Spectrometry
48. βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer’s Disease
49. Abstract 5048: Residual concentrations of cetuximab predict clinical response in head and neck cancer patients
50. A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.